Skip to main content
. 2021 Jul 30;11(8):1374. doi: 10.3390/diagnostics11081374

Table 1.

Pros and cons of each MPUS method and molecular test.

PROS CONS
Qualitative USE
  • Non-invasive

  • No contrast medium

  • Safe

  • Same probe and US machine of B-mode evaluation

  • Defined in some guidelines

  • Not overly time-consuming

  • Good intra-observed agreement

  • Subjective evaluation (low inter-observed agreement)

  • Non-univocal classification (4- or 5-point scale scoring systems)

  • Soft carcinoma evaluation (thyroid follicular carcinoma)

  • Undefined thyroiditis influence

  • Calcific nodule may be wrongly assessed

  • Cystic nodule may be wrongly assessed

Semi-Quantitative USE
  • Non-invasive

  • No contrast medium

  • Safe

  • Same probe and US machine of B-mode evaluation

  • Defined in some guidelines

  • Not overly time-consuming

  • Good intra-observed agreement

  • Good inter-observed agreement

  • Univocal cut-off missing

  • Soft carcinoma evaluation (thyroid follicular carcinoma)

  • Undefined thyroiditis influence

  • Calcific nodule may be wrongly assessed

  • Cystic nodule may be wrongly assessed

Quantitative USE
  • Non-invasive

  • No contrast medium

  • Safe

  • Same probe and US machine of B-mode evaluation

  • Defined in some guidelines

  • Not overly time-consuming

  • Good intra-observed agreement

  • Good inter-observed agreement

  • Univocal cut-off missing

  • Two different measurement units (m/s and kPa)

  • Soft carcinoma evaluation (thyroid follicular carcinoma)

  • Undefined thyroiditis influence

  • Calcific nodule may be wrongly assessed

  • Cystic nodule may be wrongly assessed

CEUS qualitative
  • Minimally invasive

  • Safe (anaphylactic reactions very rare)

  • Same probe and US machine of B-mode evaluation

  • Sulfur-based contrast medium use

  • Not approved in clinical practice by the guidelines (only approved for research)

  • Undefined intra-observed agreement

  • Undefined inter-observed agreement

  • More time-consuming than USE

CEUS quantitative (T/I curve)
  • Minimally invasive

  • Safe (anaphylactic reactions very rare)

  • Same probe and US machine of B-mode evaluation

  • Sulfur-based contrast medium use

  • Not approved in clinical practice by the guidelines (only approved for research)

  • Undefined intra-observed agreement

  • Undefined inter-observed agreement

  • More time-consuming than USE

US CAD System
  • Non-invasive

  • No contrast medium

  • Safe

  • Same probe and US machine of B-mode evaluation

  • Not overly time-consuming

  • Good intraobserved agreement

  • Good interobserved agreement

  • Improves the accuracy of inexperienced or non-specialist radiologists

  • Not approved in clinical practice by the guidelines (only approved for research)

  • Accuracy not superior to experienced radiologists

Molecular test
  • May be performed on cytological specimens

  • Cost-effective only in carefully selected nodules

  • Variable performance according to the pre-test probability of malignancy

  • High costs (still unavailable/unaffordable in many countries)